PeerView | Urology

Free CME from PeerView

Urology CME

PVI, PeerView Institute for Medical Education

New Data and Clinical Context: An Update on Renal Cell Carcinoma Care in Early Through Advanced Disease

Sumanta Kumar Pal, MD

June 21, 2021

Medical Learning Institute, Inc.

The New Therapeutic Era in Renal Cell Carcinoma: Essentials for Team-Based Patient Care

May 17, 2021

Purdue University College of Pharmacy

Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice

Evan J. Lipson, MD

May 11, 2021

Medical Learning Institute, Inc.

Enhancing Personalized Medicine in Advanced Ovarian Cancer: Expert Guidance on Integrating the Latest Updates on PARP Inhibitors and Novel Therapeutic Innovations Into Your Clinical Practice

May 11, 2021

Medical Learning Institute, Inc.

Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation

Suresh S. Ramalingam, MD, FACP, FASCO

May 11, 2021

Medical Learning Institute, Inc.

Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors

Susana Banerjee, MBBS, MA, FRCP, PhD

May 07, 2021

Penn State College of Medicine

The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care

Matthew D. Galsky, MD

April 20, 2021

Pages